MediFind Announced as Finalist for Reuter’s Pharma Awards USA: Most Valuable Service or Digital Therapy

MediFind announced as finalist for Reuters Award

The Reuters Events’ Pharma Awards USA focus on what really matters: value for patients and customers. Recognizing innovative and meaningful approaches: this is the work worth applauding. The awards focus on initiatives that deliver outcomes, restore pharma’s reputation and celebrate real achievements.

Specifically, the Most Valuable Service or Digital Therapy category focuses on initiatives that go beyond the pill, providing a holistic service or solution that provides significant benefit to patients.

The formal awards ceremony is scheduled for December 7-9, 2020. Read more about the award and the other finalists here.

Relevant Articles

  • Fight the Contagion with Contagion—Maximizing Reach Through Better Targeting

    Now is an ideal time to re-assess strategy and increase your targeting and engagement with key HCPs, KOLs, speakers, and related individuals.

  • Primary Care Physician | The Ultimate Guide to Choosing a Primary Care Doctor

    The ultimate guide on how to find, evaluate, and choose the best primary care physician. 10-step process and checklist included.

  • Are Clinical Trials a Last Resort? Doctors Discuss the Benefits and Risks for Patients

    Are clinical trials a last resort? Should you participate in one? Doctors weigh in on the benefits, risks, and many uses of clinical trials.

    Are Clinical Trials a Last Resort for Patients